Evaluation Sub-Committee - Applications Considered
- 1357.1 - F-18 Fluorodeoxyglucose positron emission tomography for the evaluation of breast cancer
- 1405.1 - MBS Item for Pulmonary Rehabilitation (Resubmission)
- 1455 - Proton Beam Therapy for patients supported under the Medical Treatment Overseas Program
- 1466 - Vertebroplasty for severely painful osteoporotic vertebral fractures of less than 6 weeks duration
- 1498 - Serum soluble transferrin receptor
- 1510 - Emicizumab for routine prophylaxis, to prevent bleeding or reduce frequency of bleeding episodes in patients with haemophilia A (congenital factor VIII deficiency), with factor VIII inhibitors
- 1519 - Tisagenlecleucel (CTL019) for treatment of refractory CD19-positive leukaemia and lymphoma
- 1530 - Alpha-1 proteinase inhibitors for patients with demonstrated alpha-1 antitrypsin deficiency
- 1541 - The Micro-bypass Glaucoma Surgery device implementation as a standalone procedure in patients with open angle glaucoma